MarketPeel
Insider Trading Intelligence
CP

Christopher Peetz

MIRM
PRESIDENT AND CEO · MIRUM PHARMACEUTICALS, INC. · CIK 0001614740
FILING MIX · LIFETIME51%/49%
BUYS
37
SELLS
36
TOTAL VALUE
$19.59M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
198,186
AVG SELL PX
$63.34
TRADE KIND
SHOWING 73 / 73
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 22 pending
Forward-return performance of every backtestable P/S trade by Christopher Peetz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+30.00%+0.51%-0.15%+0.66%+1.37%
14d20+40.00%+2.80%+0.16%+2.64%+2.44%
30d20+55.00%+3.67%+1.23%+2.44%+0.85%
60d20+70.00%+0.87%+0.10%+0.77%-0.53%
90d20+55.00%+3.82%+2.26%+1.56%-2.79%
180d20(4 pending)+6.25%+34.68%+8.99%+25.69%+15.52%
1y20(6 pending)+7.14%+58.66%+16.27%+42.40%+55.22%
2y20(12 pending)+12.50%+106.70%+25.74%+80.96%+51.73%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MIRM · 198,186 shares · as of Jun 1, 2026
069,622139,244208,865278,487202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 37 buys / 36 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,926$96.15$665.9K198,186Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
883$99.66$88.0K194,309Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,021$98.20$100.3K195,192Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,602$94.64$246.3K221,707Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
30,000128,487Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
16,595$95.34$1.58M205,112Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
30,000$2.94$88.1K224,309Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,973$97.56$192.5K196,213Jun 1, 2026Jun 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
40,985$91.98$3.77M194,309Mar 16, 2026Mar 17, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
25,0000Mar 15, 2026Mar 17, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
50,00025,000Mar 15, 2026Mar 17, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
25,000185,294Mar 15, 2026Mar 17, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
50,000235,294Mar 15, 2026Mar 17, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
9,108$103.30$940.9K160,294Feb 2, 2026Feb 3, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
67,00067,000Jan 28, 2026Jan 30, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Jan 28, 2026Jan 30, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
43,50043,500Jan 28, 2026Jan 30, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
6,831$96.19$657.1K169,402Jan 26, 2026Jan 27, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
12,500176,233Jan 23, 2026Jan 27, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
12,50012,500Jan 23, 2026Jan 27, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,098$93.33$662.4K163,733Jan 22, 2026Jan 23, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
12,79725,593Jan 21, 2026Jan 23, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
12,797170,831Jan 21, 2026Jan 23, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALEGRANT
Gift
21,070187,500Dec 31, 2025Jan 2, 2026View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
19,133150,867Nov 18, 2025Nov 19, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
19,133$19.24$368.1K158,034Nov 18, 2025Nov 19, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
40,000$2.94$117.4K178,641Aug 11, 2025Aug 12, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40,000$62.00$2.48M138,641Aug 11, 2025Aug 12, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
40,000158,487Aug 11, 2025Aug 12, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
40,000$2.94$117.4K178,641Aug 7, 2025Aug 8, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
40,000198,487Aug 7, 2025Aug 8, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40,000$55.25$2.21M138,641Aug 7, 2025Aug 8, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
27,279$44.21$1.21M138,641Mar 17, 2025Mar 18, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
50,000165,920Mar 15, 2025Mar 18, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
50,00025,000Mar 15, 2025Mar 18, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
40,000238,487Mar 3, 2025Mar 4, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
20,608$47.19$972.5K115,920Mar 3, 2025Mar 4, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
19,392$46.61$903.9K136,528Mar 3, 2025Mar 4, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
40,000$2.94$117.4K155,920Mar 3, 2025Mar 4, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
9,102$48.22$438.9K115,920Feb 3, 2025Feb 4, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
6,837$47.92$327.7K125,022Jan 24, 2025Jan 27, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
12,50025,000Jan 23, 2025Jan 27, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
12,500131,859Jan 23, 2025Jan 27, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
153,550153,550Jan 21, 2025Jan 23, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Jan 21, 2025Jan 23, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
38,39038,390Jan 21, 2025Jan 23, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,489$42.82$320.6K119,359Jan 7, 2025Jan 8, 2025View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
65$21.05$1.4K126,848Nov 8, 2024Nov 14, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
34,013278,487Jul 23, 2024Jul 24, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
CHIEF EXECUTIVE OFFICER
34,013$2.94$99.9K126,783Jul 23, 2024Jul 24, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
817$21.05$17.2K92,770May 10, 2024May 15, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
6,013$26.19$157.5K104,112Feb 2, 2024Feb 5, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Jan 23, 2024Jan 25, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
37,50037,500Jan 23, 2024Jan 25, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
PRESIDENT AND CEO
5,209$28.03$146.0K110,125Jan 8, 2024Jan 9, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
President and CEO
5,498$25.65$141.0K115,334Jul 3, 2023Jul 5, 2023View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,256$16.92$21.3K120,832May 10, 2023May 19, 2023View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,000119,576Jan 31, 2023Feb 2, 2023View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
200,000200,000Jan 31, 2023Feb 2, 2023View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
CHIEF EXECUTIVE OFFICER
5,159$20.62$106.4K91,953Jan 9, 2023Mar 18, 2024View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
49$17.05$83569,576Nov 10, 2022Nov 14, 2022View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,500$13.57$20.3K69,527May 10, 2022May 12, 2022View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
240,000240,000Jan 6, 2022Jan 7, 2022View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00068,027Jan 6, 2022Jan 7, 2022View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
President and CEO
7,000$14.40$100.8K28,027Nov 24, 2021Nov 29, 2021View →
MIRM
MIRUM PHARMACEUTICALS, INC.
SALE
President and CEO
3,672$19.26$70.7K21,027Oct 1, 2021Oct 1, 2021View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,87524,699Sep 29, 2021Oct 1, 2021View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,453$14.62$21.2K2,824May 10, 2021May 12, 2021View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
175,000175,000Jan 7, 2021Jan 11, 2021View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
President and CEO
3,000$18.76$56.3K199,570Dec 23, 2020Dec 28, 2020View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASE
President and CEO
2,000$18.60$37.2K201,570Dec 23, 2020Dec 28, 2020View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,371$15.27$20.9K1,371Nov 10, 2020Nov 12, 2020View →
MIRM
MIRUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
170,000170,000Jan 10, 2020Jan 14, 2020View →
Other insiders · MIRM
Loading peer insiders…
About this filer
CIK 0001614740
ROLE
President and CEO
PRIMARY
MIRM
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001614740DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback